News & Analysis as of

Food and Drug Administration (FDA) › Opioid › DSCSA

Mintz - Health Care Viewpoints

2023: Another Year Chock Full of Challenges for FDA

Mintz - Health Care Viewpoints on

At the start of 2022, we reflected on what the Food and Drug Administration (FDA) had accomplished during the preceding 12 months and the challenges that could be ahead for the agency during the impending year, especially...more

BakerHostetler

BakerHostetler FDA and Pharmacy Weekly Digest

BakerHostetler on

Food/Dietary Supplements - FDA Investigation Into Salmonella Outbreak – The Food and Drug Administration (FDA) announced that it is investigating a multistate outbreak of Salmonella enteritidis it believes is linked to shell...more

2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide